Log in to save activitiesYour saved activities will show here so that you can easily access them whenever you're ready. Log in hereCME & EducationLog in to keep track of your credits.
Please confirm that you would like to log out of Medscape.
If you log out, you will be required to enter your username and password the next time you visit.
Log outCancel
Myeloma, Lymphoma, and Benign HematologyCME / ABIM MOC / CEExpand your knowledge and skills by exploring the latest data in myeloma, lymphoma, and benign hematology.
Early Disease Considerations in Triple Negative Breast Cancer CME / ABIM MOC / CEAre you looking to get up to speed about emerging research on ctDNA, systemic therapy, and managing toxicity in early-stage triple negative breast cancer? Learn more here.
Special Topics in HER2-Positive Breast CancerCME / ABIM MOC / CETop breast cancer experts cover the latest data on brain metastases in breast cancer, HER2-low breast cancer and HER2 testing.
Hodgkin LymphomaCME / ABIM MOC / CEDid you know that the historical treatment for frontline therapy for stage III/IV classic Hodgkin lymphoma (cHL) has recently changed?
Hodgkin's disease is a malignant cancer characterized by progressive enlargement of the lymph nodes, spleen, and lymphoid tissue. Hodgkin's lymphoma, or Hodgkin's cancer, is uniquely identified by the presence of Reed-Sternberg cells on microscopic examination. Hodgkin's lymphoma symptoms include night sweats, enlarged lymph nodes, splenomegaly, and back pain. Treatment entails radiotherapy or chemotherapy. Hodgkin's lymphoma prognosis is generally good, provided that the disease is detected early.
